T-Cell Immunotherapy for Cancer Pipeline Market Analysis Report
T-Cell Immunotherapy for Cancer Pipeline Market
Publicado el en “Negocios”, Idioma — English. 6 páginas.
Cancer is a leading cause of death worldwide. According to GLOBOCAN 2012, the incidence of cancer is expected to increase from 14 Million in 2012 to approximately 21 Million by 2030. Más
